Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sharps Technology, Inc. (STSS)
USD1.19
+0.03 (+2.59%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
105 Maxess Road 11747
Melville, NY, US
Melville, NY, US
CEO
Paul K. Danner
Website
sharpstechnology.com
IPO
2022-04-14
ISIN US82003F3091
Also trades on
NASDAQ Capital Market · SKYA (USD)
NASDAQ Capital Market · STSS (USD)
NASDAQ Capital Market · STSSW (USD)
Description
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company, through a digital asset treasury strategy, focuses on accumulating Solana (SOL), the native digital asset of the Solana blockchain. The company was incorporated in 2017 and is based in Melville, New York.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.19
+0.03 (+2.59%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
366.7K
Beta
2.13
Float Shares
18.38M
Free Float %
72.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -11.45% | -5.69% | -42.00% | -36.26% | -56.23% | -42.86% | -81.29% | -99.98% | -99.99% | -99.99% | -99.99% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
1.19
DCF (Unlevered)
0.41
-65.8%
DCF (Levered)
0.33
-72.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2025-08 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.33
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%—
-
EPS growth Medical - Instruments & Supplies: +16.3%+99.5% ★ Q1'26: -103.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-130,984.4% Q1'26: -1,388.7% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-132,235.3% Q1'26: -2,368.6% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-105.0% Q1'26: -11.0% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+604,286.1% Q1'26: +145,210.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-0.01× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. |
Dec 2027 1 Rev. Ana. |
|---|---|---|---|---|---|---|
| Revenue |
—
est: 20.00M (-100.0%)
|
—
est: 10.30B (-100.0%)
|
—
est: 44.60M (-100.0%)
|
204.1K
est: 1.60M (-87.2%)
|
72.40M
72.40M – 72.40M
+4,425.0% YoY
|
79.60M
79.60M – 79.60M
+9.9% YoY
|
| EBITDA |
-2.66M
|
-8.98M
|
-6.85M
est: 26.76M (-125.6%)
|
-269.74M
est: 960.0K (-28,197.4%)
|
43.44M
43.44M – 43.44M
+4,425.0% YoY
|
47.76M
47.76M – 47.76M
+9.9% YoY
|
| EBIT |
-3.32M
|
-9.87M
|
-7.62M
est: 26.76M (-128.5%)
|
-269.92M
est: 960.0K (-28,216.5%)
|
43.44M
43.44M – 43.44M
+4,425.0% YoY
|
47.76M
47.76M – 47.76M
+9.9% YoY
|
| Net Income |
-4.64M
|
-9.84M
est: -19.35M (+49.1%)
|
-9.30M
est: -25.05B (+100.0%)
|
-282.50M
est: -27.84M (-914.9%)
|
—
— – —
+100.0% YoY
|
—
— – —
|
| SGA |
6.45M
|
8.52M
|
7.14M
est: 887.19M (-99.2%)
|
19.49M
est: 31.83M (-38.8%)
|
1.44B
1.44B – 1.44B
+4,425.0% YoY
|
1.58B
1.58B – 1.58B
+9.9% YoY
|
| EPS |
-3,780.28
|
-4,983.99
est: -4,620.00 (-7.9%)
|
-2,220.05
est: -990.00 (-124.2%)
|
-11.16
est: -1.10 (-914.5%)
|
—
— – —
+100.0% YoY
|
—
— – —
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | B- | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-5.96M
OE per share TTM
-0.08
Owner's Yield
-7.08%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
10,967.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
7
Total invested
3.01M
Insider transactions (90d)
0
Beneficial owners (>5%)
5
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Empery Asset Management, LP | 5.32M | 9.99% | — | 5.32M | — | — | PN | Delaware | 2024-01-09 | ↗ |
| 2 | Martin D. Hoe | 5.32M | 9.99% | — | 5.32M | — | — | IN | Delaware | 2024-01-09 | ↗ |
| 3 | Ryan M. Lane | 5.32M | 9.99% | — | 5.32M | — | — | IN | Delaware | 2024-01-09 | ↗ |
| 4 | Walleye Capital LLC | 1.00M | 6.55% | 1.00M | — | 1.00M | — | IA | Minnesota | 2024-02-14 | ↗ |
| 5 | Loewenstein | 885.7K | 9.60% | 628.6K | 257.1K | 628.6K | 257.1K | IN | United States | 2022-04-21 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
7
-16 vs prev Q
New positions
5
Closed positions
21
Increased
6
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | SCHONFELD STRATEGIC ADVISORS LLC | 1.54M +— (+0.0%) | 3.05M -6.4M (-67.6%) | 6.32% +0.000 pp | 0.01% -0.040 pp | USD6.52 -68.9% | 2 qtrs — |
| 2 | SCOGGIN MANAGEMENT LP | 1.15M +1.2M (+100.0%) | 2.33M +2.3M (+100.0%) | 4.72% +4.725 pp | 0.36% +0.358 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 3 | PANTERA CAPITAL PARTNERS LP | 1.15M +— (+0.0%) | 2.33M -5.2M (-68.9%) | 4.72% +0.000 pp | 1.02% +0.064 pp | USD6.52 -68.9% | 2 qtrs — |
| 4 | HBK INVESTMENTS L P | 769.2K +769.2K (+100.0%) | 1.45M +1.4M (+100.0%) | 3.16% +3.160 pp | 0.01% +0.011 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 5 | VANGUARD GROUP INC | 521.6K +503.8K (+2,822.5%) | 1.06M +942.5K (+809.9%) | 2.14% +2.070 pp | 0.00% +0.000 pp | USD2.18 -6.9% | 2 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 280.4K +268.9K (+2,349.9%) | 569.2K +494.5K (+662.8%) | 1.15% +1.105 pp | 0.00% +0.000 pp | USD2.21 -8.1% | 2 qtrs — |
| 7 | SABA CAPITAL MANAGEMENT, L.P. | 202.8K +202.8K (+100.0%) | 411.6K +411.6K (+100.0%) | 0.83% +0.833 pp | 0.01% +0.012 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 8 | BLACKROCK, INC. | 94.5K +94.5K (+100.0%) | 191.9K +191.9K (+100.0%) | 0.39% +0.388 pp | 0.00% +0.000 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 9 | NORTHERN TRUST CORP | 60.7K +60.7K (+100.0%) | 123.2K +123.2K (+100.0%) | 0.25% +0.249 pp | 0.00% +0.000 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 10 | — | 33.5K +33.5K (+100.0%) | 68.1K +68.1K (+100.0%) | 0.14% +0.138 pp | 0.08% +0.085 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 20.8K +20.8K (+100.0%) | 43.0K +43.0K (+100.0%) | 0.09% +0.086 pp | 0.00% +0.000 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 12 | XTX TOPCO LTD | 15.4K +3.3K (+27.5%) | 31.3K -47.6K (-60.3%) | 0.06% +0.014 pp | 0.00% -0.003 pp | USD5.55 -63.4% | 2 qtrs — |
| 13 | ARISTIDES CAPITAL LLC | 12.1K +12.1K (+100.0%) | 24.6K +24.6K (+100.0%) | 0.05% +0.050 pp | 0.00% +0.004 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 14 | ENGINEERS GATE MANAGER LP | 11.2K +11.2K (+100.0%) | 22.7K +22.7K (+100.0%) | 0.05% +0.046 pp | 0.00% +0.000 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 15 | MORGAN STANLEY | 8.6K -4.4K (-33.9%) | 17.6K -67.7K (-79.4%) | 0.04% -0.018 pp | 0.00% +0.000 pp | USD6.52 -68.9% | 2 qtrs — |
| 16 | UBS GROUP AG | 7.8K +5.8K (+292.2%) | 15.9K +2.9K (+22.1%) | 0.03% +0.024 pp | 0.00% +0.000 pp | USD2.91 -30.2% | 3 qtrs — |
| 17 | BANK OF AMERICA CORP /DE/ | 241.00 -7.7K (-97.0%) | 489.00 -51.1K (-99.1%) | 0.00% -0.032 pp | 0.00% +0.000 pp | USD6.52 -68.9% | 3 qtrs — |
| 18 | SIMPLEX TRADING, LLC | 218.00 +218.0 (+100.0%) | 442.00 +442.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.03 +0.0% | 1 qtrs NEW |
| 19 | HM PAYSON & CO | 35.00 +20.0 (+133.3%) | 72.00 -26.0 (-26.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.46 -41.3% | 3 qtrs — |
| 20 | ORG PARTNERS LLC | 15.00 +— (+0.0%) | 30.00 -67.0 (-69.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.40 -62.4% | 3 qtrs — |
| 21 | TOWER RESEARCH CAPITAL LLC (TRC) | — -1.7K (-100.0%) | — -11.2K (-100.0%) | 0.00% -0.007 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 22 | CITIGROUP INC | — -1.3K (-100.0%) | — -8.6K (-100.0%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 23 | BNP PARIBAS ARBITRAGE, SNC | — -500.0 (-100.0%) | — -3.3K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 24 | OMERS ADMINISTRATION CORP | — -81.3K (-100.0%) | — -530.3K (-100.0%) | 0.00% -0.334 pp | 0.00% -0.004 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 143.5K | 0.60% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
2
Shares acquired
—
Shares disposed
107.5K
Cash buys
—
Cash sales
2.00
Net activity
-107,465
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-16 | Saba Capital Management, L.P. | 10% Owner | S-Sale | D | Common Stock | 12,182 | 2.37 | 28.9K | 1,511,988 | I | ↗ |
| 2026-01-15 | Saba Capital Management, L.P. | 10% Owner | S-Sale | D | Common Stock | 25,000 | 2.30 | 57.5K | 1,524,170 | I | ↗ |
| 2026-01-14 | Saba Capital Management, L.P. | 10% Owner | S-Sale | D | Common Stock | 77,688 | 2.25 | 174.8K | 1,549,170 | I | ↗ |
| 2026-01-13 | Saba Capital Management, L.P. | 10% Owner | S-Sale | D | Common Stock | 29,777 | 2.19 | 65.2K | 1,626,858 | I | ↗ |
| 2026-01-12 | FalconX Holdings Ltd | 10% Owner | S-Sale | D | Common Stock | 47,281 | 1.97 | 92.9K | 0 | I | ↗ |
| 2026-01-09 | Saba Capital Management, L.P. | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 1,656,635 | I | ↗ |
| 2026-01-09 | FalconX Holdings Ltd | 10% Owner | X-InTheMoney | A | Common Stock | 461,538 | 0.00 | 46.15 | 461,538 | I | ↗ |
| 2026-01-08 | Saba Capital Management, L.P. | 10% Owner | — | — | Cash Stapled Warrants | 1,538,462 | 9.75 | 15.00M | 0 | I | ↗ |
| 2025-11-04 | Saba Capital Management, L.P. | 10% Owner | — | — | Pre-Funded Warrants | 388,462 | 6.50 | 2.53M | 0 | I | ↗ |
| 2025-10-14 | FalconX Holdings Ltd | 10% Owner | — | — | Cryptocurrency Stapled Warrants | 4,871,192 | 9.75 | 47.49M | 0 | I | ↗ |
| 2025-08-27 | Ruemler Timothy James | Director | S-Sale | D | Common Stock | 5,000 | 16.58 | 82.9K | 35,218 | D | ↗ |
| 2025-08-25 | Ruemler Timothy James | Director | P-Purchase | D | Common Stock | 5,000 | 10.63 | 53.2K | 30,218 | D | ↗ |
| 2025-08-23 | Zhang Yuwen | Director / Officer | A-Award | A | Stock Option | 500,000 | 6.41 | 3.21M | 500,000 | D | ↗ |
| 2025-08-22 | Simpson Brenda Baird | Director | P-Purchase | A | Option (right to buy) | 20,000 | 6.41 | 128.2K | 20,000 | D | ↗ |
| 2025-08-22 | Ruemler Timothy James | Director | P-Purchase | A | Option (right to buy) | 80,000 | 6.41 | 512.8K | 80,000 | D | ↗ |
| 2025-08-22 | Monroe Jason L. | Director | P-Purchase | A | Option (right to buy) | 80,000 | 6.41 | 512.8K | 80,000 | D | ↗ |
| 2025-08-22 | Hayes Robert Michael | Director | P-Purchase | A | Option (right to buy) | 100,000 | 6.41 | 641.0K | 100,000 | D | ↗ |
| 2025-08-22 | DANNER PAUL K | Director | P-Purchase | A | Option (right to buy) | 400,000 | 6.41 | 2.56M | 400,000 | D | ↗ |
| 2025-08-22 | Crescenzo Andrew R. | Director / Officer | P-Purchase | A | Option (right to buy) | 40,000 | 6.41 | 256.4K | 40,000 | D | ↗ |
| 2025-08-22 | Christiansen Soren Bo | Director | P-Purchase | A | Option (right to buy) | 80,000 | 6.41 | 512.8K | 80,000 | D | ↗ |
| 2025-07-15 | DANNER PAUL K | Director | P-Purchase | A | Series B Preferred Stock | 5 | 20.00 | 100.00 | 5 | D | ↗ |
| 2025-05-01 | BANK OF AMERICA CORP /DE/ | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-30 | BANK OF AMERICA CORP /DE/ | 10% Owner | — | — | COMMON STOCK | 0 | 0.00 | — | 0 | I | ↗ |
| 2025-03-31 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 125,000 | 0.03 | 3.8K | 400,882 | D | ↗ |
| 2025-02-28 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 175,000 | 0.04 | 7.0K | 275,882 | D | ↗ |
| 2024-12-05 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 500 | 2.16 | 1.1K | 100,882 | D | ↗ |
| 2024-12-04 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 300 | 1.94 | 582.00 | 96,182 | D | ↗ |
| 2024-04-26 | Simpson Brenda Baird | Director | P-Purchase | A | Stock Option (right to buy) | 75,000 | 0.29 | 21.4K | 175,000 | — | ↗ |
| 2024-04-26 | Ruemler Timothy James | Director | P-Purchase | A | Stock Option (right to buy) | 75,000 | 0.29 | 21.4K | 346,429 | — | ↗ |
| 2024-04-26 | Monroe Jason L. | Director | P-Purchase | A | Stock Option (right to buy) | 75,000 | 0.29 | 21.4K | 175,000 | — | ↗ |
| 2024-04-26 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Stock Option (right to buy) | 150,000 | 0.29 | 42.8K | 664,286 | — | ↗ |
| 2024-04-26 | DANNER PAUL K | Director | P-Purchase | A | Stock Option (right to buy) | 250,000 | 0.29 | 71.3K | 378,571 | — | ↗ |
| 2024-04-26 | Crescenzo Andrew R. | Officer | P-Purchase | A | Stock Option (right to buy) | 100,000 | 0.29 | 28.5K | 176,518 | — | ↗ |
| 2024-04-26 | Christiansen Soren Bo | Director | P-Purchase | A | Stock Option (right to buy) | 100,000 | 0.29 | 28.5K | 427,142 | — | ↗ |
| 2024-02-20 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.34 | 3.4K | 95,882 | — | ↗ |
| 2024-02-06 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.29 | 2.9K | 85,882 | — | ↗ |
| 2024-02-02 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 8,000 | 0.35 | 2.8K | 75,882 | — | ↗ |
| 2024-01-31 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 0.39 | 390.00 | 67,882 | — | ↗ |
| 2024-01-03 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 5,000 | 0.40 | 2.0K | 1,061,675 | — | ↗ |
| 2024-01-02 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 4,466 | 0.40 | 1.8K | 1,056,675 | — | ↗ |
| 2023-12-28 | Crescenzo Andrew R. | Officer | P-Purchase | A | Common Stock | 3,500 | 0.42 | 1.5K | 15,500 | — | ↗ |
| 2023-12-22 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 10,000 | 0.40 | 4.0K | 1,052,209 | — | ↗ |
| 2023-11-22 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 10,000 | 0.45 | 4.5K | 1,042,209 | — | ↗ |
| 2023-11-20 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 5,000 | 0.41 | 2.1K | 1,022,209 | — | ↗ |
| 2023-11-17 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 5,000 | 0.41 | 2.1K | 1,021,209 | — | ↗ |
| 2023-11-16 | Ruemler Timothy James | Director / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.42 | 415.00 | 1,017,209 | — | ↗ |
| 2023-11-15 | Ruemler Timothy James | Director / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.41 | 1.0K | 1,013,709 | — | ↗ |
| 2023-04-14 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 1.28 | 5.1K | 65,682 | — | ↗ |
| 2023-03-15 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 600 | 1.37 | 822.00 | 61,682 | — | ↗ |
| 2023-03-14 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.34 | 1.3K | 59,582 | — | ↗ |
| 2023-03-13 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.34 | 1.3K | 58,582 | — | ↗ |
| 2023-02-22 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 500 | 1.34 | 670.00 | 56,582 | — | ↗ |
| 2023-02-21 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.37 | 1.4K | 56,082 | — | ↗ |
| 2023-02-17 | Hayes Robert Michael | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.34 | 1.3K | 54,582 | — | ↗ |
| 2023-01-25 | Simpson Brenda Baird | Director | P-Purchase | A | Stock Option (right to buy) | 90,000 | 0.00 | — | 90,000 | — | ↗ |
| 2023-01-25 | Ruemler Timothy James | Director | P-Purchase | A | Stock Option (right to buy) | 90,000 | 0.00 | — | 90,000 | — | ↗ |
| 2023-01-25 | Monroe Jason L. | Director | P-Purchase | A | Stock Option (right to buy) | 90,000 | 0.00 | — | 90,000 | — | ↗ |
| 2023-01-25 | Hayes Robert Michael | Officer | P-Purchase | A | Stock Option (right to buy) | 330,000 | 0.00 | — | 330,000 | — | ↗ |
| 2023-01-25 | DANNER PAUL K | Director | P-Purchase | A | Stock Option (right to buy) | 90,000 | 0.00 | — | 90,000 | — | ↗ |
| 2023-01-25 | Crescenzo Andrew R. | Officer | P-Purchase | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2023-01-25 | Christiansen Soren Bo | Director | P-Purchase | A | Stock Option (right to buy) | 135,000 | 0.00 | — | 135,000 | — | ↗ |
| 2023-01-25 | Blackman Alan R. | Director | P-Purchase | A | Stock Option (right to buy) | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-09-02 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 2,000 | 1.35 | 2.7K | 53,082 | — | ↗ |
| 2022-08-30 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 82 | 1.34 | 109.88 | 46,082 | — | ↗ |
| 2022-08-26 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 1.41 | 1.4K | 39,000 | — | ↗ |
| 2022-08-22 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 1.34 | 1.3K | 36,000 | — | ↗ |
| 2022-08-04 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 1.19 | 1.2K | 32,000 | — | ↗ |
| 2022-07-29 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 1.00 | 1.0K | 28,700 | — | ↗ |
| 2022-07-14 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 200 | 1.01 | 202.00 | 27,700 | — | ↗ |
| 2022-05-20 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 1.21 | 1.2K | 25,000 | — | ↗ |
| 2022-05-09 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 112,000 | 1.25 | 140.0K | 1,011,209 | — | ↗ |
| 2022-05-06 | Crescenzo Andrew R. | Officer | P-Purchase | A | Common Stock | 637 | 1.30 | 828.10 | 12,000 | — | ↗ |
| 2022-05-04 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 1.38 | 1.4K | 19,000 | — | ↗ |
| 2022-05-03 | Simpson Brenda Baird | Director | P-Purchase | A | Stock Option (right to buy) | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-05-03 | Monroe Jason L. | Director | P-Purchase | A | Stock Option (right to buy) | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-05-03 | Hayes Robert Michael | Officer | P-Purchase | A | Stock Option (right to buy) | 70,000 | 0.00 | — | 70,000 | — | ↗ |
| 2022-05-03 | DANNER PAUL K | Director | P-Purchase | A | Stock Option (right to buy) | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-05-03 | Crescenzo Andrew R. | Officer | P-Purchase | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-05-03 | Christiansen Soren Bo | Officer | P-Purchase | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-05-03 | Berler Barry Boris | Officer | P-Purchase | A | Stock Option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-05-02 | Ruemler Timothy James | Director | P-Purchase | A | Common Stock | 8,800 | 1.21 | 10.6K | 899,206 | — | ↗ |
| 2022-04-28 | Blackman Alan R. | Officer | P-Purchase | A | Common Stock | 10,000 | 1.25 | 12.5K | 763,429 | — | ↗ |
| 2022-04-27 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 1.44 | 1.4K | 14,000 | — | ↗ |
| 2022-04-27 | Blackman Alan R. | Officer | P-Purchase | A | Common Stock | 10,000 | 1.25 | 12.5K | 743,429 | — | ↗ |
| 2022-04-25 | Blackman Alan R. | Officer | P-Purchase | A | Common Stock | 5,000 | 1.37 | 6.9K | 733,429 | — | ↗ |
| 2022-04-22 | Blackman Alan R. | Officer | P-Purchase | A | Common Stock | 5,000 | 1.52 | 7.6K | 728,429 | — | ↗ |
| 2022-04-20 | Crescenzo Andrew R. | Officer | P-Purchase | A | Common Stock | 6,000 | 2.26 | 13.6K | 6,000 | — | ↗ |
| 2022-04-19 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 1,000 | 2.28 | 2.3K | 9,000 | — | ↗ |
| 2022-04-14 | Simpson Brenda Baird | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-04-14 | Ruemler Timothy James | Director | — | D | Common Stock | 0 | 0.00 | — | 861,006 | — | ↗ |
| 2022-04-14 | Monroe Jason L. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-04-14 | Hayes Robert Michael | Officer | P-Purchase | A | Common Stock | 5,000 | 2.30 | 11.5K | 5,000 | — | ↗ |
| 2022-04-14 | Christiansen Soren Bo | Director | — | D | Common Stock | 0 | 0.00 | — | 162,857 | — | ↗ |
| 2022-04-14 | Blackman Alan R. | Officer | P-Purchase | A | Common Stock | 4,000 | 4.25 | 17.0K | 723,429 | — | ↗ |
| 2022-04-14 | Berler Barry Boris | Officer | — | D | Common Stock | 0 | 0.00 | — | 885,714 | — | ↗ |
| 2021-09-30 | Crescenzo Andrew R. | Officer | — | D | Option (Right to Buy) | 804 | 7.00 | 5.6K | 0 | — | ↗ |
| 2021-09-30 | Christiansen Soren Bo | Director | — | D | Option (Right to Buy) | 5,714 | 7.00 | 40.0K | 0 | — | ↗ |
| 2021-09-15 | Ruemler Timothy James | Director | — | D | Option (Right to Buy) | 28,571 | 7.00 | 200.0K | 0 | — | ↗ |
| 2021-09-15 | DANNER PAUL K | Director | — | D | Option (Right to Buy) | 28,571 | 7.00 | 200.0K | 0 | — | ↗ |
| 2021-09-09 | Hayes Robert Michael | Director / Officer | — | D | Option (Right to Buy) | 114,286 | 7.00 | 800.0K | 0 | — | ↗ |
| 2021-01-01 | Blackman Alan R. | Director / Officer | — | D | Option (Right to Buy) | 38,571 | 7.00 | 270.0K | 0 | — | ↗ |
| 2021-01-01 | Berler Barry Boris | Officer | — | D | Option (Right to Buy) | 38,571 | 7.00 | 270.0K | 0 | — | ↗ |
| 2020-11-12 | Ruemler Timothy James | Director | — | D | Option (Right to Buy) | 142,857 | 4.38 | 625.7K | 0 | — | ↗ |
| 2020-10-01 | Christiansen Soren Bo | Director | — | D | Option (Right to Buy) | 42,857 | 4.38 | 187.7K | 0 | — | ↗ |
| 2019-12-31 | Crescenzo Andrew R. | Officer | — | D | Option (Right to Buy) | 7,143 | 4.38 | 31.3K | 0 | — | ↗ |
| 2018-10-04 | Christiansen Soren Bo | Director | — | D | Option (Right to Buy) | 85,714 | 2.80 | 240.0K | 0 | — | ↗ |
| 2018-03-31 | Christiansen Soren Bo | Director | — | D | Option (Right to Buy) | 42,857 | 1.75 | 75.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-142.1K
Shares Outstanding
25.52M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Paul Kruger Danner | Executive Chairman and Principal Executive & Financial Officer | 1M | male |
| Yuwen Zhang | Chief Investment Officer & Director | 212.5K | female |
| Arthur R. Levine | Interim Chief Financial Officer | — | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for STSS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
